Skip to main content
    P

    Progyny Inc (PGNY)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $36.71
    -0.44 (-1.18%)

    Market Cap: $2.74B

    Last updated: Nov 17, 2026 at 4:30 PM ET

    Progyny Inc (PGNY) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Progyny (PGNY) has a market cap of $2.74B and an enterprise value of $2.62B. Its share count is down 11.38% from a year earlier.

    Total Valuation

    Enterprise value is 4.27% below the market cap, as cash exceeds debt.

    Market Cap$2.74B
    Enterprise Value$2.62B
    Latest price (Nov 17, 2026)$36.71

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 2.48% in the quarter ended Sep 30, 2026 and shrank 8.00% a year over 2 years.

    Shares Outstanding76.23M
    Shares Change (YoY)-11.38%
    Shares Change (QoQ)-2.48%
    Share Count Growth (2Y CAGR)-8.00%

    Valuation Ratios

    Sales and book value multiples are 2.1x and 6.8x. Its year-end P/E ranged from 10.5x to 353.3x from 2020 to 2025.

    P/E Ratio28.5x
    Forward P/E28.0x
    P/S Ratio2.1x
    Forward P/S2.0x
    P/B Ratio6.8x
    P/TBV Ratio7.2x
    P/FCF Ratio15.6x
    P/OCF Ratio13.2x
    PEG Ratio1.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 19.3x EBITDA and 14.9x free cash flow.

    EV / Earnings28.8x
    EV / Sales2.0x
    EV / EBITDA19.3x
    EV / EBIT19.8x
    EV / FCF14.9x

    Price Statistics

    The stock is up 49.53% over 52 weeks and trades 27.02% above its 50-day average.

    Beta (1Y)-0.09
    52-Week Change+49.53%
    1-Month Change+31.86%
    3-Month Change+43.79%
    6-Month Change+49.23%
    5-Year Change-52.48%
    Total Return (1Y)+49.53%
    Total Return (3Y CAGR)+4.47%
    Total Return (5Y CAGR)-9.15%
    Return vs SPY (1Y)+30.45%
    Max Drawdown (1Y)-42.65%
    Max Drawdown (3Y)-67.16%
    Sharpe Ratio (1Y)0.71
    Correlation with SPY (1Y)-0.03
    50-Day Average$28.90
    200-Day Average$24.95
    52-Week Range$16.10 to $37.20
    RSI (14 Days)77.8
    Average Volume (20 Days)1.06M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.93x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio1.93x
    Quick Ratio1.93x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 21.98% over the last 12 months, against a 5-year average of 13.92%.

    Return on Equity (ROE)21.98%
    Return on Assets (ROA)13.47%
    Return on Capital Employed (ROCE)30.36%
    ROE (5Y Average)13.92%
    ROA (5Y Average)9.80%
    ROIC (5Y Average)12.02%
    Asset Turnover1.82x
    Receivables Turnover5.28x

    Taxes

    Income tax took 31.20% of pretax income over the last 12 months.

    Income Tax (TTM)$41.27M
    Effective Tax Rate31.20%

    Scores

    PGNY has an Altman Z-Score of 10.02, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score10.02
    Altman Z ZoneSafe
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.34B over the last 12 months is up 5.52% from the 12 months before.

    Revenue$1.34B
    Revenue Growth (YoY)+5.52%
    Gross Profit$332.99M
    Operating Income$125.79M
    Pretax Income$132.29M
    Net Income$91.02M
    EBITDA$138.91M
    EBIT$132.29M
    Reported EPS (TTM)$1.29

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 61.27% of the $675.79M in total assets.

    Cash and Equivalents$116.82M
    Total Debt$0
    Net Cash$116.82M
    Net Cash Per Share$1.53
    Working Capital$224.36M
    Shareholder Equity$414.03M
    Book Value Per Share$5.43
    Tangible Book Value$388.67M
    Tangible Book Per Share$5.10
    Total Assets$675.79M
    Total Liabilities$261.76M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $27.55M of capital spending, operating cash flow left $179.64M of free cash flow.

    Operating Cash Flow$207.18M
    Capital Expenditures$27.55M
    Free Cash Flow$179.64M
    FCF Per Share$2.34
    Depreciation and Amortization$6.62M
    Share Repurchases$313.06M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 9.40%, against a 5-year average of 5.51%.

    Gross Margin24.87%
    Operating Margin9.40%
    Pretax Margin9.88%
    Net Margin6.80%
    EBITDA Margin10.38%
    EBIT Margin9.88%
    FCF Margin13.42%
    Gross Margin (5Y Average)22.19%
    Operating Margin (5Y Average)5.51%
    Net Margin (5Y Average)6.38%

    Growth

    Revenue grew 17.87% a year over 3 years, and EPS 61.34% a year.

    Revenue Growth (3Y CAGR)+17.87%
    Revenue Growth (5Y CAGR)+30.17%
    EPS Growth (3Y CAGR)+61.34%
    EPS Growth (5Y CAGR)+60.04%
    FCF Growth (3Y CAGR)+35.46%
    FCF Growth (5Y CAGR)+40.39%
    Operating Income Growth (3Y CAGR)+54.02%
    Book Value Per Share Growth (2Y CAGR)+2.47%
    Tangible Book Per Share Growth (2Y CAGR)+0.93%

    Revenue and profit by year

    Dividends and Yields

    PGNY does not pay a dividend. Its free cash flow yield is 6.42%.

    Earnings Yield3.51%
    FCF Yield6.42%
    Buyback Yield11.14%
    Shareholder Yield11.14%

    Peer Position

    Against 10 similar companies, PGNY has the 8th highest P/E and the 4th highest P/S.

    P/E Ratio28.5x vs 48.1x median
    P/S Ratio2.1x vs 0.8x median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.52% vs +11.08% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 9.33% and EPS growth at 38.09% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+9.33%
    EPS Growth Forecast (2Y CAGR)+38.09%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PGNY

    What is PGNY's market cap?

    Progyny has a market cap of $2.74B. Its enterprise value, which adds debt and subtracts cash, is $2.62B.

    What is PGNY's P/E ratio?

    Progyny has a trailing P/E ratio of 28.5x and a forward P/E of 28.0x.

    How many shares of PGNY are outstanding?

    Progyny has 76.23M shares outstanding. The count is down 11.38% from a year earlier.

    Does PGNY pay a dividend?

    No. Progyny does not pay a dividend.

    How much debt does PGNY have?

    Progyny has $0 of total debt and $116.82M of cash and equivalents, a net cash position of $116.82M.